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Abstract
Aims/hypothesis The Di@bet.es Study is the first national
study in Spain to examine the prevalence of diabetes and
impaired glucose regulation.
Methods A population-based, cross-sectional, cluster sam-
pling study was carried out, with target population being
the entire Spanish population. Five thousand and seventy-two
participants in 100 clusters (health centres or the equivalent
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DOI 10.1007/s00125-011-2336-9in each region) were randomly selected with a probability
proportional to population size. Participation rate was
55.8%. Study variables were a clinical and demographic
structured survey, lifestyle survey, physical examination
(weight, height, BMI, waist and hip circumference, blood
pressure) and OGTT (75 g).
Results Almost 30% of the study population had some
carbohydrate disturbance. The overall prevalence of diabe-
tes mellitus adjusted for age and sex was 13.8% (95% CI
12.8, 14.7%), of which about half had unknown diabetes:
6.0% (95% CI 5.4, 6.7%). The age- and sex-adjusted
prevalence rates of isolated impaired fasting glucose (IFG),
isolated impaired glucose tolerance (IGT) and combined
IFG–IGT were 3.4% (95% CI 2.9, 4.0%), 9.2% (95% CI
8.2, 10.2%) and 2.2% (95% CI 1.7, 2.7%), respectively.
The prevalence of diabetes and impaired glucose regulation
increased significantly with age (p<0.0001), and was
higher in men than in women (p<0.001).
Conclusions/interpretation The Di@bet.es Study shows,
for the first time, the prevalence rates of diabetes and
impaired glucose regulation in a representative sample of
the Spanish population.
Keywords Epidemiology.Prevalence.Spain.Type 2
diabetes mellitus
Abbreviations
FPG Fasting plasma glucose
IFG Impaired fasting glucose
IGR Impaired glucose regulation
IGT Impaired glucose tolerance
KDM Known diabetes mellitus
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Introduction
Quantifying the number of people with diabetes is
important because it allows for planning and rational
judgement of resources. In Europe the prevalence of
diabetes varies between studies [1]. The reasons for this
are multiple, and include the different methodologies
employed. Notably, only two national studies exist (Iceland
and Portugal) [2]. Despite the importance for the design of
strategies for diabetes, the data available on the prevalence
of diabetes in different countries are limited.
In Spain, numerous studies have attempted to establish
the prevalence of diabetes at different levels [3]. Most have
shown prevalence rates of diabetes between 10% and 15%,
indicating that the established estimates have probably been
surpassed [3].
We undertook, for the first time in Spain, a representa-
tive study of the prevalence of diabetes and IGR for the
whole country, and evaluated its association with various
risk factors
Methods
Population The Di@bet.es Study was a national, cross-
sectional, population-based survey conducted in 2009–10. A
cluster sampling designwas used to select participants, forming
a representative random sample of the Spanish population. Of
the eligible adults, 55.8% attended for examination, of whom
9.9% were excluded by protocol (institutionalised, severe
disease, pregnancy or recent delivery), giving a final sample
of 5,072 individuals aged ≥18 years (41.6% men and 58.4%
women). Of these, 1,952 (38.5%) did not receive an OGTT:
481 with previously diagnosed diabetes, 87 with fasting
c a p i l l a r yg l y c a e m i a> 7 . 8m m o l / l ,a n d1 , 3 8 4w h or e f u s e dt h e
OGTT. The study was approved by the Ethics and Clinical
Investigation Committee of Carlos Haya Hospital, and written
informed consent was obtained from all participants.
Variables and procedures The participants were invited to
attend a single examination visit at their health centre.
Information was collected using a structured, interviewer-
administered questionnaire, followed by a physical examina-
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Diabetologia (2012) 55:88–93 89tion. Fieldwork was undertaken by seven teams, each
comprising a nurse and dietitian. After the interview, a fasting
blood sample was obtained and a standard OGTT performed.
Age, sex, education level, smoking, level of daily physical
activity (at work), leisure time sports and family history of
diabetes (first and/or second degree relatives) were recorded.
Weight, height and waist and hip circumferences were
measured by standardised methods. The BMI and WHR were
calculated. Blood pressure was measured using a blood
pressure monitor (Hem-703 C, Omron, Barcelona, Spain) after
several minutes in a seated position; the mean of two measure-
ments taken 1–2 min apart was used for analysis.
Subjects with baseline capillary blood glucose levels lower
than 7.8 mmol/l and not receiving treatment for diabetes
underwentastandardOGTT,obtainingfastingand2hvenous
samples. Samples were immediately centrifuged and serum
was frozen until analysis. Serum glucose, triacylglycerols and
cholesterol were measured enzymatically, and HDL-
cholesterolbya directmethod.LDL-cholesterolwasestimated
by the Friedewald formula. Diabetes was diagnosed and
classified according to the 1999 WHO criteria [4].
Statistical analysis The global prevalence was adjusted for
the age and sex structure of the Spanish population. Not all
the participants agreed to undergo the OGTT, and the
prevalence of unknown diabetes mellitus (UKDM) was
therefore calculated as: (number of diagnosed OGTT cases/
number of participants who underwent the OGTT)×(1−
known diabetes mellitus [KDM] prevalence). The preva-
lence of IGR was calculated similarly [5].
Participants who accepted the OGTT were 2 years older
than those who did not (49.2 vs 47.0 years, p<0.001), but
there were no significant differences in sex or BMI between
the two groups.
Associations between diabetes mellitus–IGR phenotypes
and various risk factors were tested by logistic regression
analyses, controlling for age, sex and BMI. Reported p values
are based on two-sided tests with statistical significance set
at 0.05.
Results
Almost 30% of the study population had some glucose
disturbance. The total prevalence (95% CI) of diabetes
mellitus adjusted for age and sex was 13.8% (12.8, 14.7%).
Of these, almost half did not know they had the disease
(6.0% [5.4, 6.7%]). Isolated IFG was present in 3.4% (2.9,
4.0%) and isolated IGT in 9.2% (8.2, 10.2%). The
prevalence of participants with combined IFG–IGT was
2.2% (1.7, 2.2%). The prevalence of diabetes mellitus and
IGR increased significantly with age (p<0.0001), and was
greater in men than women (p<0.001) (Table 1).
The prevalence of obesity, abdominal obesity and hyper-
tension was significantly higher in all diabetes–IGR pheno-
types (Table 2). The probability of having raised
triacylglycerol or low HDL-cholesterol levels was signifi-
cantly higher in participants with KDM and UKDM, but the
probability of having raised LDL-cholesterol was lower in
Table 1 Prevalence of diabetes and impaired glucose regulation according to sex and age
Variable Age (years)
18–30 31–45 46–60 61–75 >76
Men
n 306 603 578 494 193
Isolated IFG 0.32 (−0.31, 0.96) 2.32 (1.11, 3.52) 6.74 (4.70, 8.79) 4.85 (2.96, 6.75) 6.21 (2.81, 9.62)
Isolated IGT 2.84 (0.59, 5.09) 6.28 (3.91, 8.64) 10.8 (7.58, 14.1) 12.9 (9.02, 16.8) 16.9 (10.1, 23.7)
Combined IFG–IGT 0.47 (−0.45, 1.40) 2.41 (0.92, 3.91) 1.51 (0.23, 2.79) 4.22 (1.88, 6.56) 3.38 (0.10, 6.66)
UKDM 0.0 4.53 (2.87, 6.20) 11.9 (9.34, 14.6) 17.6 (14.2, 21.0) 16.7 (11.4, 22.0)
KDM 0.32 (−0.31, 0.96) 2.15 (0.99, 3.31) 11.9 (9.29, 14.5) 24.8 (21.0, 28.7) 20.7 (15.0, 26.4)
Women
n 369 853 818 608 250
Isolated IFG 0.81 (−0.1, 1.72) 1.99 (1.05, 2.93) 5.74 (4.15, 7.34) 5.09 (3.35, 6.84) 4.00 (1.57, 6.42)
Isolated IGT 3.89 (1.52, 6.26) 3.95 (2.28, 5.62) 6.99 (4.83, 9.15) 10.9 (7.82, 14.0) 20.2 (13.5, 26.9)
Combined IFG–IGT 0.38 (−0.37, 1.15) 1.31 (0.34, 2.29) 1.74 (0.63, 2.86) 2.73 (1.10, 4.36) 6.01 (2.07, 9.95)
UKDM 0.31 (−0.2, 0.87) 1.28 (0.53, 2.04) 4.32 (2.93, 5.71) 11.1 (8.60, 13.6) 18.1 (13.3, 22.9)
KDM 0.27 (−0.25, 0.80) 0.93 (0.29, 1.58) 6.60 (4.89, 8.30) 18.7 (15.6, 21.8) 23.2 (17.9, 28.4)
Data are % (95% CI)
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education level was more frequent in participants with KDM.
The probability of smoking, doing exercise in their free
time at least once weekly and the intensity of work activity
did not differ significantly between the different metabolic
phenotypes (Table 2).
The prevalence of a family history of diabetes (first and/
or second degree relative) was greater in all diabetes–IGR
phenotypes (Table 2).
Finally, the multivariate logistic regression analysis
showed that the presence of diabetes mellitus was significant-
ly associated with age (OR [95% CI] 1.05 [1.04, 1.06]), sex
(less frequent in women [OR 0.34 (0.28, 0.45)]), education
level (greater risk in persons without education [OR 1.28
(1.02, 1.62)]), obesity (OR 1.70 [1.37, 2.05]), abdominal
obesity (OR 2.20 [1.75, 2.76]), high blood pressure (OR 2.26
[1.77, 2.87]), low HDL-cholesterol (OR 1.54 [1.25, 1.91]),
high triacylglycerols (OR 1.99 [1.60, 2.48]) and a family
history of diabetes (OR 2.70 [2.21, 3.31]).
Discussion
The present study, using a representative sample of the
whole national population, shows that the prevalence of
diabetes mellitus in Spain is 13.8%, with 6.8% having
UKDM discovered during the study fieldwork.
A total of 13 studies from nine European countries (three
from Spain) were included in the Decode Study, involving
7,680 men and 9,251 women aged 30–89 years. The
Table 2 Association between diabetes and impaired glucose regulation categories and various risk factors
Variable Normal
OGTT
IFG IGT IFG + IGT UKDM KDM p value
n 3,760 198 309 80 244 481
Age (years) 46.3±16.0 57.6±12.6 59.7±16.1 60.1±15.9 62.8±13.7 65.6±11.5 <0.0001
a
Obesity (BMI ≥30 kg/m
2) % 23.2 51.2 48.2 53.8 60.2 50.2 <0.0001
b
OR (95% CI) 1 2.8 (1.9, 4.1) 2.5 (1.9, 3.2) 3.4 (2.1, 5.5) 4.2 (3.1, 5.5) 2.4 (2.0, 3.1)
Abdominal obesity (WHR
>1 in men or WHR >0.85
in women)
% 33.1 52.7 57.9 70.5 65.1 68.1 <0.0001
b
OR (95% CI) 1 2.2 (1.4, 3.4) 2.2 (1.6, 2.9) 4.3 (2.4, 7.7) 3.8 (2.7, 5.3) 3.5 (2.7, 4.5)
Hypertension
(antihypertensive
treatment or a systolic BP
≥140 mmHg and/or
diastolic BP ≥90 mmHg)
% 34.3 67.8 69.5 77.2 79.1 83.3 <0.0001
c
OR (95% CI) 1 1.9 (1.2, 2.9) 1.7 (1.2, 2.3) 2.5 (1.3, 4.6) 2.2 (1.5, 3.3) 2.5 (1.9, 3.4)
High LDL-cholesterol (≥3.9
mmol/l)
% 6.6 9.5 8.3 11.1 8.8 4.4 0.07
d
OR (95% CI) 1 1.3 (0.7, 2.06) 0.9 (0.6, 1.4) 1.3 (0.6, 2.8) 0.8 (0.6, 1.4) 0.4 (0.2, 0.7)
High triacylglycerols
(≥1.7 mmol/l)
% 15.4 29.6 34.2 36.1 45.6 39.4 <0.0001
c
OR (95% CI) 1 1.4 (0.9, 2.3) 2.0 (1.5, 2.6) 1.9 (1.1, 3.2) 3.0 (2.2, 4.0) 2.4 (1.9, 3.1)
Low HDL-cholesterol (<1.0
mmol/l in men or 1.3
mmol/l in women)
% 29.1 38.6 34.2 34.7 39.4 48.4 <0.0001
c
OR (95% CI) 1 1.3 (0.6, 1.5) 1.2 (0.9, 1.6) 1.1 (0.6, 1.8) 1.5 (1.1, 2.0) 2.4 (1.8, 2.9)
Low education level (no
education or only primary
studies)
% 8.5 19.2 21.6 27.5 25.8 31.5 0.03
c
OR (95% CI) 1 1.29 (0.86, 1.95) 1.24 (0.88, 1.72) 1.74 (0.98, 3.07) 1.38 (0.98, 1.95) 1.66 (1.29, 2.14)
Smokers (more than one
cigarette/day)
% 28.4 25.2 15.7 23.2 29.9 15.8 0.19
c
OR (95% CI) 1 1.34 (0.86, 2.09) 0.72 (0.51, 1.02) 1.21 (0.67, 2.18) 1.16 (0.82, 1.66) 0.90 (0.68, 1.19)
Have an active job style % 14.1 16.5 8.9 10.0 9.1 8.2 0.06
c
OR (95% CI) 1 1.46 (0.87, 2.44) 0.70 (0.45, 1.08) 0.80 (0.36, 1.78) 0.71 (0.44, 1.16) 0.67 (0.47, 0.97)
Do leisure exercise at least
once a week
% 39.8 33.9 32.5 32.9 35.9 30.2 0.09
c
OR (95% CI) 1 0.91 (0.61, 1.37) 0.80 (0.61, 1.05) 0.88 (0.52, 1.49) 0.96 (0.71, 1.30) 0.72 (0.57, 0.90)
Family history of diabetes
mellitus (first and/or
second degree relative)
% 47.1 53.3 45.2 46.8 49.6 62.7 <0.0001
c
OR (95% CI) 1 1.70 (1.14, 2.53) 1.38 (1.06, 1.80) 1.37 (0.33, 2.28) 1.67 (1.24, 2.26) 3.47 (2.76, 4.36)
OR were obtained by logistic regression models adjusted for sex, age and BMI where indicated
aAdjusted for sex
bAdjusted for age and sex
cAdjusted for age, sex and BMI
dAdjusted for age, sex, BMI and statin therapy
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countries the prevalence of diabetes and IGR is moderate or
low (<10% in people younger than 60 and 10–20% in
people aged 60–80 years) [5].
Other studies on diabetes mellitus prevalence have been
undertaken in other European countries with data obtained
from case records or from structured interviews, but with
no OGTT. In other cases, local studies are extrapolated to
the total national territory, and this may or may not
represent the prevalence over the whole country. There
may also exist important differences between countries in
the prevalence of obesity, physical activity or eating
patterns, which might partially explain the variation in
diabetes prevalence [6].
In a recent Portuguese study using the same methodol-
ogy as ours, the total prevalence of diabetes mellitus was
11.7%, very similar to that for the Spanish population [2].
In both studies diabetes mellitus prevalence was signifi-
cantly higher in men than women. In our study, the
prevalence of KDM was somewhat greater and UKDM
somewhat less than that published in earlier studies in Spain
[3] and Portugal [2]. The prevalence of IFG and IGT was
also lower than that found in earlier Spanish studies [3]o r
recently in Portugal [2], where the prevalence of IFG and
IGT was 23%. Different health strategies, different meth-
odologies or a different prevalence of obesity or other
metabolic risk factors might explain these differences in
contemporary studies in which the overall diabetes mellitus
prevalence was very similar.
In our study, diabetes mellitus and IGR were signifi-
cantly associated with a greater frequency of obesity, high
blood pressure, hypertriacylglycerolaemia and low HDL-
cholesterol as expected [7]. However, people with KDM
probably receive statin therapy more frequently, which may
explain the lower level of LDL-cholesterol in people with
KDM.
Finally, people with a low educational level had a 28%
increased risk of having diabetes mellitus after adjustment
for other risk factors closely associated with diabetes. A
lower socioeconomic level has been associated with a
poorer state of health, higher rates of mortality and
cardiovascular diseases, and an increase in diabetes
prevalence [8].
The main strengths of this study are first, the sampling was
representative of the whole national territory, and second, the
diagnosis of diabetes was made by OGTT in the majority of
cases. The study, however, has a few limitations: the
participation was relatively low (56%) and there was a greater
participation of women and older people, meaning all the
prevalence and analysis data were corrected for age and sex.
In addition, not all the participants underwent the OGTT, but
the prevalence of diabetes mellitus and IGR was calculated
taking this into account, as indicated in the Methods section.
Although, for clinical purposes, an OGTT needs to be
reassessed to establish diagnostic status, it is widely accepted
that one OGTT is enough in the setting of epidemiological
studies. Another limitation is that the information was self-
reported, although this, too, is common practice in large
epidemiological surveys.
In summary, this study contributes information for the
first time on the prevalence of diabetes mellitus and IGR in
Spain. The results will provide our public health authorities
with data that should encourage the urgent implementation
of clinical and preventive intervention programmes to
tackle the increasing health and economic burden of
diabetes in Spain.
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